{
    "Trade/Device Name(s)": [
        "Wondfo Multi-Drug Urine Test Cup",
        "Wondfo Multi-Drug Urine Test Panel",
        "Multi-Drug Urine Test Cup",
        "Multi-Drug Urine Test Panel"
    ],
    "Submitter Information": "Guangzhou Wondfo Biotech Co., Ltd.",
    "510(k) Number": "K121166",
    "Predicate Device Reference 510(k) Number(s)": [
        "K112071"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DIO",
        "LAF",
        "DJG",
        "DJR",
        "LFG",
        "LCM"
    ],
    "Summary Letter Date": "March 26, 2012",
    "Summary Letter Received Date": "April 17, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3250",
        "21 CFR 862.3610",
        "21 CFR 862.3650",
        "21 CFR 862.3620",
        "21 CFR 862.3910",
        "21 CFR 862.3100"
    ],
    "Regulation Name(s)": [
        "Cocaine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Cocaine",
        "Methadone",
        "Methamphetamine",
        "Methylenedioxymethamphetamine",
        "Morphine",
        "Morphine 2000",
        "Phencyclidine",
        "Notriptyline"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Competitive binding",
        "Lateral flow immunochromatographic assay"
    ],
    "Methodologies": [
        "Immunochromatographic assay"
    ],
    "Submission Type(s)": [
        "Panel",
        "Cup",
        "Multiplex",
        "Cassette",
        "Strip test"
    ],
    "Document Summary": "FDA 510(k) summary for Wondfo Multi-Drug Urine Test Cup and Panel for qualitative simultaneous detection of drugs of abuse using lateral flow immunochromatographic assay in urine.",
    "Indications for Use Summary": "Qualitative and simultaneous detection of Cocaine, Methadone, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Morphine 2000, Phencyclidine, Notriptyline in human urine at specified cutoff concentrations; provides preliminary results requiring confirmatory testing.",
    "fda_folder": "Toxicology"
}